AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
6857.T
ACCE-researched

Advantest Corporation (6857.T) fair value

Technology · Semiconductor Equipment & Materials · TSE · Japan
¥32340.00-0.09%
Market cap ¥23.35TNext earnings 2026-10-28Updated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: there are no financial statements on file yet.
ACCE opinionAdvantest Corporation (6857.T)
Fair value
Not available
ACCE price target
¥31550
Rating
Not rated
Horizon
12 months
ACCE price target published on 22 Oct 2026, 15:59 CEST.
Price used: ¥32340 at the close on 23 Oct 2026, 08:30 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
77
out of 100
P/E
51.3x
forward 136.0x
1-year return
+96.4%
Dividend yield
0.19%

Advantest Corporation in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Advantest makes automated test equipment for semiconductors, chiefly the SoC testers used to validate logic chips for AI accelerators and the memory test handlers and probers that feed them, with a test-system franchise that has been built up over decades in a niche where qualification cycles are long and switching is costly. The structural case rests on that installed base and on the rising test intensity of advanced packaging and high-bandwidth memory, where every additional chip layer adds test steps. Reported revenue growth of 39.3% and an operating margin of 51.7% show that demand is currently flowing through to the bottom line rather than being absorbed by price competition. The trailing P/E of 54.6 looks full, but the forward P/E of 136.2 implies the market is pricing earnings to fall sharply from current levels, which is worth testing before accepting the trailing figure as a sign of value. Cyclicality in semiconductor capex and concentration among a few large customers are the main risks to this read, so the question for a deeper look is whether the order book supports the margin structure through a downturn.

AI-assisted·How I use AIWritten Oct 23, 2026
⚠ Investor warnings · 1 flagAI-assisted·How I use AI
  • moderate
    Rich valuation multiples
    P/E of 51.3 and EV/EBITDA of 42.3, with forward P/E of 136.2, leave little room for earnings to disappoint. Price trades 2.5% above the ACCE price target of ¥31550.00.

AI research notes

AI-assisted·How I use AIWritten Oct 22, 2026 · figures from 2026-10-22 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 39.3% over the latest year, well above its 32.7% average annual pace over five years.
  • Net margin of 37.3% and return on equity of 56.9% show the business turns sales into unusually high profit.
  • Latest earnings per share beat expectations by 42.9%, coming in at 241.27 against 168.82 expected.
Why it could disappoint
  • At 136.2x forward earnings against 51.3x trailing, the earnings outlook is too unclear to value the shares confidently.
  • The share price of ¥32340.00 sits 2.5% above the ACCE price target of ¥31550.00.
  • Analysts' mean price target of JPY 42733.33 implies upside, but the dividend yield of 0.2% offers little income while investors wait.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where 6857.T's valuation models land
Price
¥32340.00
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-6.3%
1 month
+0.9%
3 months
+11.7%
6 months
+9.9%
YTD
+64.7%
1 year
+96.4%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
22 Oct 2026, 15:59 CESTACCE price target¥31550first publication¥32370

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in JPY. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full 6857.T page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth100Value16Quality100Momentum90Total77
Valuation
Trailing P/E
51.3x
Forward P/E
136.0x
PEG
0.56
P/B
no data
EV / Revenue
no data
Book value/sh
no data
Enterprise value
no data
Profitability
ROE
56.9%
FCF yield
1.50%
ROIC
no data
Health and risk
Debt / equity
0.10
Dividend yield
0.19%
Beta
no data

Price

+89.3% · 1Y

Ask anything about 6857.T

Answered from Advantest Corporation fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 0% of peers
low 32.0x51.3xhigh 51.3x
ROEbetter than 50% of peers
low 27%57%high 88%
Div yieldbetter than 17% of peers
low 0.1%0.2%high 0.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
6857.T Advantest Corporation¥32340.00--51.3x56.9%10077
KLAC KLA Corporation Common Stock$147.83$9063% above44.7x87.5%9159
LRCX Lam Research Corporation Common Stock$230.15$15647% above40.0x65.1%9265
AMAT Applied Materials Inc. Common Stock$375.58$22070% above32.5x41.1%9267
TER Teradyne Inc. Common Stock$308.75$102202% above47.4x36.5%9667
ASM.AS ASM International NV€709.20€44161% above32.0x26.8%9666
ASML ASML Holding N.V. New York Registry Shares$1560.54$89774% above38.4x65.6%9675

Sector report card

Where 6857.T ranks against its sector peers on each metric.

Computing percentiles…